Corrigendum to "Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy".

[This corrects the article DOI: 10.4061/2011/924595.].

In the article titled “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy” [1], there was an error regarding the FRAX® tool, which should be clarified as follows.

The article notes, “Fracture Risk Assessment (FRAX) is an algorithm developed by the World Health Organization to determine fracture risk of men and women [8].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.